PLEURAL EFFUSION, MALIGNANT
Clinical trials for PLEURAL EFFUSION, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new PLEURAL EFFUSION, MALIGNANT trials appear
Sign up with your email to follow new studies for PLEURAL EFFUSION, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Doctors reprogram Patients' own cells to attack advanced lung cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a new personalized immunotherapy for people with advanced cancer that has spread to the lining of the lungs (pleura). Doctors take immune cells from a patient's own lung fluid, grow large numbers of them in a lab, and then infuse th…
Matched conditions: PLEURAL EFFUSION, MALIGNANT
Phase: PHASE1 • Sponsor: David Bartlett, MD • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New lab test aims to match cancer patients with the right drug faster
Knowledge-focused Recruiting nowThis study is testing a new laboratory method to see if it can predict which cancer treatments will work best for a patient. Researchers will take a sample of a patient's tumor cells from a fluid or tissue biopsy and test how the cells react to different drugs in the lab. The goa…
Matched conditions: PLEURAL EFFUSION, MALIGNANT
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC